Biologic characteristics of 164 patients with myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 33, Issue 3-4, 1999, Pages 281-287

  Reza, Samina ^a   Dar, Saleem ^a   Andric, Tanja ^a   Qawi, Huma ^a   Mundle, Suneel ^a   Shetty, Vilasini ^a   Venugopal, Parameswaren ^a   Ali, Irfan ^a   Lisak, Laurie ^a   Raza, Azra ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Biololoy; In situ end labeling (ISEL); MDS; Myelodysplasia; TNF

Indexed keywords

CYTOKINE; HEMOGLOBIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CELL PROLIFERATION; CYTOKINE PRODUCTION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRELEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA;

EID: 0032944365     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058427     Document Type: Article

References (15)

1. Raza, A., Alvi, S., Broady-Robinson, L., Showel, M., Cartlidge, J., Mundle, S.D., Shetty, V., Borok, R.Z., Dar, S.E., Chopra, H.K., Span, L., Parcharidou, A., Hines, C., Gezer, S., Venugopal, P., Loew, J., Showel, J., Alston, D., Hernandez, B., Rifkin, S., Robin, E., Shah, R., Gregory, S. (1997) Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo-and/or bromodeoxyuridine. Experimental Hematology 25:530-535.
2. Raza, A., Alvi, S., Broady-Robinson, L., Showel, M., Cartlidge, J., Mundle, S.D., Shetty, V., Borok, Z., Dar, S.E., Chopra, H.K., Span, L., Parcharidou, A., Hines, C., Gezer, S., Venugopal, P., Loew, J., Alston, D., Hernandez, B., Rifkin, S., Robin, E., Shah, R., Gregory, S. (1997) Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: The cause-effect relationship. In Press, Leukemia and Lymphoma.
3. Raza, A., Gezer, S., Mundle, S., Gao, X-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chancy, C., Showel, J., Gregory, S., Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86(1):268-276.
4. Raza, A., Mundle, S., Shetty, V., Alvi, S., Chopra, H., Span, L., Parcharidou, A., Dar, S., Venugopal, P., Borok, R., Gezer, S., Showel, J., Loew, J., Robin, E., Rifkin, S., Alston, D., Hernandez, B., Shah, R., Kaizer, H., Gregory, S. (1996) A paradigm shift in myelodysplastic syndromes. Leukemia 10: 1648-1652.
5. Raza ,A., Mundle, S., Shetty, V., Alvi, S., Chopra, H., Dar, S., Venugopal, P., Borok, R., Gezer, S., Showel, J., Robin, E., Rifkin, S., Alston, D., Hernandez, B., Gregory, S. (1996) Novel insights into the biology of Myelodysplastic Syndromes: Excessive apoptosis and the role of cytokines. International Journal of Hematology 63:265-278.
6. Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Gregory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominquez, C., Raza, A. (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 20(11/12):891-900.
7. List, A.F., Brasfield, F., Heaton, R., Glinsmann-Gibson, B., Crook, L., Taetle, R., Capizzi, R. (1997) Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndromes. Blood 90(9):3364-3369.
8. Raza, A., Venugopal, P., Gezer, S., Gregory, S., Dong, L.M., Leurgans, S., Mundle, S.D., Shetty, V.T., Alvi, S., Ali, A., Span, L., Dar, S.E., Hines, C., Hsu, W-T., Loew, J., Borok, R.Z., Hernandez, B., Robin, E., Rifkin, S., Alston, D., Shah, R., Preisler, H.D. (1998) Pilot study of pentoxifylline and ciprofloxacin with or without dexamethasone produces encouraging results in myelodysplastic syndromes. Acute Leukemias VII: Experimental Approaches and Novel Therapies published by Springer-Verlag Berlin Heideberg, New York, (eds) W. Hiddemann, T. Buchner, B. Wormann, J. Ritter, U. Creutzig, Keating M, Plunkett W, pp42-51.
9. Raza, A., Qawi, H., Andric, T., Gezer, S., Venugopal, P., Gregory, S.A., Hines, C., Mundle, S.D., Ali, A., Shetty, V., Mativi, B., Dar, S., Loew, J., Robin, E.L., Rifkin, S.D., Alston, D., Hernandez, B.M., Shah, R. (1997) Combination of Pentoxifylline, Ciprofloxacin, Dexamethasone with Amifostine improves ineffective hematopoiesis in 70% patients with myelodysplastic syndromes. Proc Am Soc Hematol, Blood 90(10):84a, abstr #367.
10. Bennet, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199.
11. Verhoef, G., DeWolf-Peters, C., Kerim, S., Van de Broeck, J., Mecucci, C., Van den Bergh, H., Boogaerts, M.A. (1991) Update on the prognostic implication of morphology, histology and karyotype in primary myelodysplastic syndromes. Hematol Pathol 5:163-175.
12. Hellstrom-Lindberg, E., Kanter-Lewensohn, L., Ost, A. (1997) Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res 21:415-425.
13. Rajapaksa, R., Ginzton, N., Rott, L.S., Greenberg, P. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 88: 4275-4287.
14. Verhoef, G.E.G., DeSchouwer, P., Ceuppens, J.L., Van Damme, J., Goossens, W., Boogaerts, M.A. (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6(12):1268-1272.
15. Mundle, S., Iftikhar, A., Shetty, V., Dameron, S., Wright-Quinones, V., Marcus, B., Loew, J., Gregory, S., Raza, A. (1994) Novel in situ double-labeling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem 42(12): 1533-1537.